Dean Diagnosis: Progress Announcement on the Repurchase of the Company\'s Shares
Dean Diagnosis: Announcement on the controlling shareholder\'s partial share pledge
Dian Diagnostics Group: Announcement Regarding the Plan for Profit Distribution in Mid-2024
Dian Diagnostics Group: Announcement on the pledge and release of some shares by the controlling shareholder.
Dian Diagnostics Group: Announcement on the completion of share repurchase cancellation and changes in shareholding
Dian Diagnostics Group: Announcement Regarding the Pledge of Shares by the Controlling Shareholder
Dian Diagnostics Group: Announcement regarding the progress of repurchasing company shares.
Dian Diagnostics Group: Announcement on the renewal of pledge of some shares by the controlling shareholder.
Dian Diagnostics Group: Announcement on the cancellation of the pledge of some of the shares of the controlling shareholder
Dian Diagnostics Group: Shareholder dividend return plan for the next three years (2024-2026)
Dian Diagnostics Group: Announcement on the Progress of Repurchasing Company Shares to Reach 2% Proportion
Dian Diagnostics Group: Announcement regarding the progress of repurchasing company shares.
Dian Diagnostics Group: Announcement regarding the plan of partial directors, supervisors and senior management to increase their shareholding in the company.
Dian Diagnostics Group: Announcement Regarding the Change of Purposes for Repurchase of Shares and Cancellation.
Dian Diagnostics Group: Announcement on the progress of repurchasing the company's shares to reach 1% of the proportion.
Dian Diagnostics Group: Announcement on the renewal of pledge of some shares by the controlling shareholder.
Dian Diagnostics Group: Announcement on the adjustment of the maximum repurchase price after the implementation of the 2023 annual equity distribution.
Dian Diagnostics Group: Announcement of Annual Equity Distribution Implementation in 2023
Dian Diagnostics Group: Announcement Regarding the Pledge of Shares by the Controlling Shareholder
Dian Diagnostics Group: Announcement regarding the progress of repurchasing company shares.
No Data